Targeting Nrf2 may reverse the drug resistance in ovarian cancer

被引:0
|
作者
Danjie Li
Xiaoling Hong
Feijie Zhao
Xinxin Ci
Songling Zhang
机构
[1] The First Hospital of Jilin University,Department of Obstetrics and Gynecology
[2] The First Hospital of Jilin University,Institute of Translational Medicine
来源
关键词
Drug resistance; Reactive oxidative stress; Ovarian cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Targeting Nrf2 may reverse the drug resistance in ovarian cancer
    Li, Danjie
    Hong, Xiaoling
    Zhao, Feijie
    Ci, Xinxin
    Zhang, Songling
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Nrf2 and drug resistance in breast cancer cells
    Shen, Jun
    Unni, Emmanual
    Brodie, Angela
    Jaiswal, Anil
    CANCER RESEARCH, 2009, 69
  • [3] Tripterygium glycosides reverse chemotherapy resistance in ovarian cancer by targeting the NRF2/GPX4 signal axis to induce ferroptosis of drug-resistant human epithelial ovarian cancer cells
    Ma, Bo
    Zhong, Yanying
    Chen, Runqiu
    Zhan, Xinlu
    Huang, Genhua
    Xiong, Yifei
    Tan, Buzhen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 665 : 178 - 186
  • [4] Role of NRF2 in Ovarian Cancer
    Tossetta, Giovanni
    Fantone, Sonia
    Montanari, Eva
    Marzioni, Daniela
    Goteri, Gaia
    ANTIOXIDANTS, 2022, 11 (04)
  • [5] Targeting NRF2 to treat cancer
    Sivinski, Jared
    Zhang, Donna D.
    Chapman, Eli
    SEMINARS IN CANCER BIOLOGY, 2021, 76 : 61 - 73
  • [6] Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
    Kim, Eun Hye
    Jang, Hyejin
    Shin, Daiha
    Baek, Seung Ho
    Roh, Jong-Lyel
    APOPTOSIS, 2016, 21 (11) : 1265 - 1278
  • [7] How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
    Tang, Ya-Chu
    Chuang, Yung-Jen
    Chang, Hsin-Huei
    Juang, Shin-Hun
    Yen, Gow-Chin
    Chang, Jang-Yang
    Kuo, Ching-Chuan
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2023, 31 (03) : 387 - 407
  • [8] Targeting Nrf2 to treat thyroid cancer
    Gong, Zhongqin
    Xue, Lingbin
    Li, Huangcan
    Fan, Simiao
    van Hasselt, Charles Andrew
    Li, Dongcai
    Zeng, Xianhai
    Tong, Michael Chi Fai
    Chen, George Gong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [9] Targeting NRF2 signaling for cancer chemoprevention
    Kwak, Mi-Kyoung
    Kensler, Thomas W.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 244 (01) : 66 - 76
  • [10] Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
    Eun Hye Kim
    Hyejin Jang
    Daiha Shin
    Seung Ho Baek
    Jong-Lyel Roh
    Apoptosis, 2016, 21 : 1265 - 1278